Atrioventricular septal defect cardiac catheterization

Jump to navigation Jump to search

Atrioventricular septal defect Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Atrioventricular septal defect from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Cardiac Catheterization

Treatment

Medical Therapy

Surgery

Prevention

Pregnancy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Atrioventricular septal defect cardiac catheterization On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atrioventricular septal defect cardiac catheterization

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrioventricular septal defect cardiac catheterization

CDC on Atrioventricular septal defect cardiac catheterization

Atrioventricular septal defect cardiac catheterization in the news

Blogs on Atrioventricular septal defect cardiac catheterization

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Atrioventricular septal defect cardiac catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cardiac Catheterization

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[1]

Diagnostic Recommendations for Atrioventricular Septal Defect

Class IIa
1. Cardiac catheterization can be useful in adults with atrioventricular septal defect when pulmonary hypertension is suspected. (Level of Evidence: C-EO) "

2008 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)[2]

Recommendation for Heart Catheterization (DO NOT EDIT)[2]

Class IIa
"1. Cardiac catheterization is reasonable to assess PAH and test vasoreactivity in patients with repaired or unrepaired AVSD. (Level of Evidence: B) "

References

  1. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.
  2. 2.0 2.1 Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.

Template:WH Template:WS CME Category::Cardiology